Compare Redington with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

REDINGTON vs INDOCO REMEDIES - Comparison Results

REDINGTON     Change

Redington India, incorporated in 1961, commenced the operations in 1993 distributing information technology (IT) products. Now the company along with its subsidiaries is in the business of end-to-end supply chain management of IT and non- IT products... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    REDINGTON INDOCO REMEDIES REDINGTON/
INDOCO REMEDIES
 
P/E (TTM) x 10.3 74.5 13.8% View Chart
P/BV x 1.4 4.3 32.5% View Chart
Dividend Yield % 2.4 0.3 759.9%  

Financials

 REDINGTON   INDOCO REMEDIES
EQUITY SHARE DATA
    REDINGTON
Mar-19
INDOCO REMEDIES
Mar-18
REDINGTON/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs159317 50.1%   
Low Rs64178 35.9%   
Sales per share (Unadj.) Rs1,196.1113.1 1,057.8%  
Earnings per share (Unadj.) Rs12.54.5 278.8%  
Cash flow per share (Unadj.) Rs14.111.8 119.2%  
Dividends per share (Unadj.) Rs3.301.00 330.0%  
Dividend yield (eoy) %3.00.4 733.3%  
Book value per share (Unadj.) Rs100.473.2 137.1%  
Shares outstanding (eoy) m389.0892.15 422.2%   
Bonus/Rights/Conversions BB/ESOP--  
Price / Sales ratio x0.12.2 4.3%   
Avg P/E ratio x9.055.5 16.1%  
P/CF ratio (eoy) x7.921.0 37.8%  
Price / Book Value ratio x1.13.4 32.8%  
Dividend payout %26.522.4 118.4%   
Avg Mkt Cap Rs m43,38222,830 190.0%   
No. of employees `0001.65.5 28.8%   
Total wages/salary Rs m7,2422,209 327.8%   
Avg. sales/employee Rs Th295,843.31,910.1 15,488.7%   
Avg. wages/employee Rs Th4,603.9405.0 1,136.9%   
Avg. net profit/employee Rs Th3,079.975.5 4,081.9%   
INCOME DATA
Net Sales Rs m465,36210,419 4,466.3%  
Other income Rs m63247 1,348.2%   
Total revenues Rs m465,99410,466 4,452.3%   
Gross profit Rs m8,2761,349 613.4%  
Depreciation Rs m634677 93.6%   
Interest Rs m2,042235 868.4%   
Profit before tax Rs m6,233484 1,287.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,38972 1,918.1%   
Profit after tax Rs m4,845412 1,177.0%  
Gross profit margin %1.812.9 13.7%  
Effective tax rate %22.315.0 148.9%   
Net profit margin %1.04.0 26.4%  
BALANCE SHEET DATA
Current assets Rs m116,6865,373 2,171.7%   
Current liabilities Rs m80,3994,157 1,934.1%   
Net working cap to sales %7.811.7 66.8%  
Current ratio x1.51.3 112.3%  
Inventory Days Days3068 44.7%  
Debtors Days Days4973 67.6%  
Net fixed assets Rs m4,9216,244 78.8%   
Share capital Rs m778184 422.2%   
"Free" reserves Rs m38,2826,566 583.1%   
Net worth Rs m39,0606,750 578.7%   
Long term debt Rs m2451,233 19.9%   
Total assets Rs m124,20712,363 1,004.7%  
Interest coverage x4.13.1 132.5%   
Debt to equity ratio x00.2 3.4%  
Sales to assets ratio x3.70.8 444.5%   
Return on assets %5.55.2 106.0%  
Return on equity %12.46.1 203.4%  
Return on capital %21.19.0 233.7%  
Exports to sales %00-   
Imports to sales %8.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m38,631NA-   
Fx inflow Rs m1,4423,762 38.3%   
Fx outflow Rs m38,9361,143 3,405.3%   
Net fx Rs m-37,4942,619 -1,431.7%   
CASH FLOW
From Operations Rs m10,6841,227 870.6%  
From Investments Rs m-944-1,360 69.4%  
From Financial Activity Rs m-6,507-388 1,678.3%  
Net Cashflow Rs m3,240-521 -622.4%  

Share Holding

Indian Promoters % 0.0 59.2 -  
Foreign collaborators % 21.0 0.0 -  
Indian inst/Mut Fund % 7.5 12.5 60.0%  
FIIs % 37.3 6.0 621.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 34.1 22.4 152.2%  
Shareholders   14,740 12,805 115.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare REDINGTON With:   IL&FS INV. MANAGERS  COX & KINGS  NALWA SONS INV  MOTILAL OSWAL  EDELWEISS FINANCIAL  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views on News

REDINGTON Announces Quarterly Results (3QFY20); Net Profit Up 26.4% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, REDINGTON has posted a net profit of Rs 2 bn (up 26.4% YoY). Sales on the other hand came in at Rs 148 bn (up 17.1% YoY). Read on for a complete analysis of REDINGTON's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

REDINGTON Announces Quarterly Results (2QFY20); Net Profit Up 38.0% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, REDINGTON has posted a net profit of Rs 1 bn (up 38.0% YoY). Sales on the other hand came in at Rs 123 bn (up 11.1% YoY). Read on for a complete analysis of REDINGTON's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

REDINGTON SHARE PRICE


Jan 22, 2021 (Close)

TRACK REDINGTON

  • Track your investment in REDINGTON with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE REDINGTON WITH

MARKET STATS